Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alyna Turner

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Eclinicalmedicine|July 26, 2021
N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trialRebecca McKetin, Olivia M Dean, Alyna Turner, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 10, 2025
The efficacy of adjunctive <i>Garcinia mangostana</i> Linn. (mangosteen) pericarp extract for bipolar depression: 24-week randomised controlled trialOlivia M Dean, Susan M Cotton, Melanie M Ashton, et al.
Trials|June 21, 2024
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina TrialRebecca McKetin, Tayla J Degan, Lucy Saunders, et al.
Depression and Anxiety|September 22, 2018
Shortening self-report mental health symptom measures through optimal test assembly methods: Development and validation of the Patient Health Questionnaire-Depression-4Miyabi Ishihara, Daphna Harel, Brooke Levis, et al.
JAMA Psychiatry|April 1, 2026
Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical TrialRebecca McKetin, Steven Shoptaw, Lucy Saunders, et al.
Journal of Clinical Psychopharmacology|March 13, 2026
The Candesartan Adjunctive Depression Trials-CADET: Study Protocols for Double-Blind, Randomized, Placebo-Controlled Trials for Bipolar Depression and Major Depressive DisorderMelanie M Ashton, Chun Hui J Park, Brisa S Fernandes, et al.
Journal of Psychosomatic Research|October 17, 2020
Depression prevalence using the HADS-D compared to SCID major depression classification: An individual participant data meta-analysisEliana Brehaut, Dipika Neupane, Brooke Levis, et al.
Psychological Medicine|July 13, 2019
Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysisYin Wu, Brooke Levis, Kira E Riehm, et al.
Journal of Clinical Epidemiology|February 28, 2020
Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysisBrooke Levis, Andrea Benedetti, John P A Ioannidis, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 3, 2018
Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviewsBrooke Levis, Andrea Benedetti, Kira E Riehm, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Eclinicalmedicine|July 26, 2021
N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trialRebecca McKetin, Olivia M Dean, Alyna Turner, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 10, 2025
The efficacy of adjunctive <i>Garcinia mangostana</i> Linn. (mangosteen) pericarp extract for bipolar depression: 24-week randomised controlled trialOlivia M Dean, Susan M Cotton, Melanie M Ashton, et al.
Trials|June 21, 2024
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina TrialRebecca McKetin, Tayla J Degan, Lucy Saunders, et al.
Depression and Anxiety|September 22, 2018
Shortening self-report mental health symptom measures through optimal test assembly methods: Development and validation of the Patient Health Questionnaire-Depression-4Miyabi Ishihara, Daphna Harel, Brooke Levis, et al.
JAMA Psychiatry|April 1, 2026
Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical TrialRebecca McKetin, Steven Shoptaw, Lucy Saunders, et al.
Journal of Clinical Psychopharmacology|March 13, 2026
The Candesartan Adjunctive Depression Trials-CADET: Study Protocols for Double-Blind, Randomized, Placebo-Controlled Trials for Bipolar Depression and Major Depressive DisorderMelanie M Ashton, Chun Hui J Park, Brisa S Fernandes, et al.
Journal of Psychosomatic Research|October 17, 2020
Depression prevalence using the HADS-D compared to SCID major depression classification: An individual participant data meta-analysisEliana Brehaut, Dipika Neupane, Brooke Levis, et al.
Psychological Medicine|July 13, 2019
Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysisYin Wu, Brooke Levis, Kira E Riehm, et al.
Journal of Clinical Epidemiology|February 28, 2020
Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysisBrooke Levis, Andrea Benedetti, John P A Ioannidis, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 3, 2018
Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviewsBrooke Levis, Andrea Benedetti, Kira E Riehm, et al.
Pageof 12